No Detail Found!

In-silico, synthesis, structure elucidation and anticancer activity study of 2-(3,4-dichlorophenyl)-4H-benzo[d][1,3]oxazin-4-one

Author(s)
Dini Kesuma Pharmaceutical Chemistry Department, Faculty of Pharmacy University of Surabaya,Surabaya,Indonesia
Tegar Achsendo Yuniarta Pharmaceutical Chemistry Department, Faculty of Pharmacy University of Surabaya,Surabaya,Indonesia
Galih Satrio Putra Pharmaceutical Chemistry Department, Faculty of Pharmacy University of Surabaya, Surabaya, Indonesia; Department of Chemistry, Faculty of Mathematics and Natural Sciences, State University of Malang, Malang, Indonesia
Sumari Sumari Department of Chemistry, Faculty of Mathematics and Natural Sciences, State University of Malang,Malang,Indonesia
Melanny Ika Sulistyowaty Pharmaceutical Sciences Department, Faculty of Pharmacy Airlangga University,Surabaya,Indonesia
Farida Anwari Medical Laboratory Science, University of Anwar Medika,Sidoarjo,Indonesia
Abstract
The research aims to synthesize 2-(3,4-dichlorophenyl)-4H-benzo[d][1,3]oxazin-4-one and evaluate its anticancer activity against MCF-7. This compound was selected based on in-silico study conducted against several dihalophenylbenzoxazinone analogues using molecular docking towards Methionyl-tRNA synthetase. Synthesis of target compound was carried out using anthranilic acid and 3,4-dichlorobenzoyl chloride. The resulting compound was characterized using various spectroscopic analysis: 1D and 2D NMR, infrared and MS. In-silico studies was performed by MVD. Several designed compounds were docked into the active site on Methionyl-tRNA Synthetase (1PG2). Anticancer activity was evaluated by MTT Assay against MCF-7. 2-(3,4-dichlorophenyl)-4H-benzo[d][1,3]oxazin-4-one has been successfully synthesized with decent amount of yield 88 %. Its spectroscopic analysis 1D and 2D NMR, MS, FTIR has proven the chemical structure of compound. In-silico studies toward the enzyme showed docking score of 76.04 Kcal/mol, higher than its native ligand (-93.50 Kcal/mol). Meanwhile, MTT assay result against MCF-7 showed IC50 value of 68.59ppm. Based on preliminary in-silico studies inhibited Methionyl-tRNA Synthetase, 2-(3,4dichlorophenyl)-4H-benzo[d][1,3]oxazin-4-one was synthesized and tested in-vitro against MCF-7. Albeit the compound does not possess better docking score than native ligand, it is still argued that benzoxazine ring can be considered as a potential anticancer agent, as showed by MTT assay result which indicated moderate cytotoxicity.
Publication Details
Page(s) 1391-1398
Published Journal: Pakistan Journal of Pharmaceutical Sciences, Volume: 35, Issue: 5, Year: 2022

Request the full text from PASTIC

Keywords
Anticancer, MTT assay, benzoxazinone, elucidation, molecular docking.
0

Citations

0

Downloads

89

Views